ATE309988T1 - Neue pyridin- und quinolin-derivate - Google Patents
Neue pyridin- und quinolin-derivateInfo
- Publication number
- ATE309988T1 ATE309988T1 AT03704539T AT03704539T ATE309988T1 AT E309988 T1 ATE309988 T1 AT E309988T1 AT 03704539 T AT03704539 T AT 03704539T AT 03704539 T AT03704539 T AT 03704539T AT E309988 T1 ATE309988 T1 AT E309988T1
- Authority
- AT
- Austria
- Prior art keywords
- quinoline derivatives
- new pyridine
- pyridine
- new
- quinoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02003115 | 2002-02-13 | ||
PCT/EP2003/001112 WO2003068748A1 (en) | 2002-02-13 | 2003-02-05 | Novel pyridine- and quinoline-derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE309988T1 true ATE309988T1 (de) | 2005-12-15 |
Family
ID=27675615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03704539T ATE309988T1 (de) | 2002-02-13 | 2003-02-05 | Neue pyridin- und quinolin-derivate |
Country Status (21)
Country | Link |
---|---|
US (1) | US6800650B2 (de) |
EP (1) | EP1476429B1 (de) |
JP (1) | JP4216197B2 (de) |
KR (1) | KR100618752B1 (de) |
CN (1) | CN1308311C (de) |
AR (1) | AR038419A1 (de) |
AT (1) | ATE309988T1 (de) |
AU (1) | AU2003206834B2 (de) |
BR (1) | BR0307576A (de) |
CA (1) | CA2474460C (de) |
DE (1) | DE60302336T2 (de) |
ES (1) | ES2252656T3 (de) |
GT (1) | GT200300038A (de) |
MX (1) | MXPA04007743A (de) |
PA (1) | PA8566201A1 (de) |
PE (1) | PE20030922A1 (de) |
PL (1) | PL372488A1 (de) |
RU (1) | RU2285693C2 (de) |
TW (1) | TW200303303A (de) |
UY (1) | UY27666A1 (de) |
WO (1) | WO2003068748A1 (de) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE374181T1 (de) | 2001-06-27 | 2007-10-15 | Smithkline Beecham Corp | Fluorpyrrolidine als dipeptidylpeptidaseinhibitoren |
DE60322224D1 (de) * | 2002-08-08 | 2008-08-28 | Takeda Pharmaceutical | Kondensierte heterozyklische verbindungen als petidase inhibitoren |
US20040242566A1 (en) | 2003-03-25 | 2004-12-02 | Syrrx, Inc. | Dipeptidyl peptidase inhibitors |
JP4806628B2 (ja) | 2003-05-05 | 2011-11-02 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤 |
EP1625122A1 (de) | 2003-05-14 | 2006-02-15 | Takeda San Diego, Inc. | Dipeptidylpeptidase-hemmer |
US7169926B1 (en) | 2003-08-13 | 2007-01-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7678909B1 (en) | 2003-08-13 | 2010-03-16 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7579357B2 (en) | 2003-08-13 | 2009-08-25 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
WO2005026148A1 (en) | 2003-09-08 | 2005-03-24 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
DE10348022A1 (de) * | 2003-10-15 | 2005-05-25 | Imtm Gmbh | Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen |
PE20050444A1 (es) * | 2003-10-31 | 2005-08-09 | Takeda Pharmaceutical | Compuestos de piridina como inhibidores de la peptidasa |
JP2007509898A (ja) | 2003-11-03 | 2007-04-19 | プロビオドルグ エージー | 神経障害治療に有用な組合せ |
EP1713780B1 (de) | 2004-02-05 | 2012-01-18 | Probiodrug AG | Neue inhibitoren von glutaminylcyclase |
US7732446B1 (en) | 2004-03-11 | 2010-06-08 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
BRPI0418639B8 (pt) | 2004-03-15 | 2021-05-25 | Takeda Pharmaceutical | compostos inibidores de dipeptidil peptidase, assim como composição farmacêutica contendo os mesmos |
EP2305352A1 (de) | 2004-04-02 | 2011-04-06 | Merck Sharp & Dohme Corp. | 5-alpha-Reduktaseinhibitoren zur Behandlung von Stoffwechsel- und anthropometrischen Störungen |
US7687638B2 (en) | 2004-06-04 | 2010-03-30 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
WO2006019965A2 (en) | 2004-07-16 | 2006-02-23 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
CA2579768A1 (en) * | 2004-09-09 | 2006-03-16 | Howard Florey Institute Of Experimental Physiology And Medicine | Enzyme inhibitors and uses thereof |
EP1828192B1 (de) | 2004-12-21 | 2014-12-03 | Takeda Pharmaceutical Company Limited | Dipeptidylpeptidasehemmer |
DOP2006000008A (es) | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 |
JP4572759B2 (ja) * | 2005-07-06 | 2010-11-04 | セイコーエプソン株式会社 | 半導体装置及び電子機器 |
US8106090B2 (en) | 2005-07-20 | 2012-01-31 | Eli Lilly And Company | 1-amino linked compounds |
AU2006278039B2 (en) * | 2005-08-11 | 2010-10-21 | F. Hoffmann-La Roche Ag | Pharmaceutical composition comprising a DPP-lV inhibitor |
CN101374523B (zh) | 2005-09-14 | 2012-04-11 | 武田药品工业株式会社 | 用于治疗糖尿病的二肽基肽酶抑制剂 |
JP5122462B2 (ja) | 2005-09-16 | 2013-01-16 | 武田薬品工業株式会社 | ジペプチジルペプチダーゼ阻害剤 |
GB0526291D0 (en) | 2005-12-23 | 2006-02-01 | Prosidion Ltd | Therapeutic method |
WO2007112347A1 (en) | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
BRPI0710110A2 (pt) | 2006-03-31 | 2011-08-02 | Novartis Ag | compostos orgánicos |
DK1971862T3 (da) | 2006-04-11 | 2011-02-14 | Arena Pharm Inc | Fremgangsmåder til anvendelse af GPR119-receptor til identificering af forbindelser anvendelige til øgning af knoglemasse hos en person |
PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
SI2073810T1 (sl) * | 2006-09-13 | 2011-12-30 | Takeda Pharmaceutical | Uporaba 2-6(3-amino-piperidin-1-il)-3-metil-2,4-diokso-3,4-dihidro-2H-pirimidin -1-ilmetil-4-fluoro-benzonitrila za zdravljenje diabetesa, raka, avtoimunskih motenj in infekcije s HIV |
JP5379692B2 (ja) | 2006-11-09 | 2013-12-25 | プロビオドルグ エージー | 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての3−ヒドロキシ−1,5−ジヒドロ−ピロール−2−オン誘導体 |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US9126987B2 (en) | 2006-11-30 | 2015-09-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
DK2142514T3 (da) | 2007-04-18 | 2015-03-23 | Probiodrug Ag | Thioureaderivater som glutaminylcyclase-inhibitorer |
JP2011509261A (ja) * | 2008-01-07 | 2011-03-24 | シンタ ファーマシューティカルズ コーポレーション | 炎症および免疫関連用途向けの化合物 |
EP2108960A1 (de) | 2008-04-07 | 2009-10-14 | Arena Pharmaceuticals, Inc. | Verfahren zur Verwendung eines A G Protein-gekoppelten Rezeptors zur Identifikation von Peptid YY (PYY) Sekretagoga und nützliche Verbindungen zur Behandlung von durch (PYY) Sekretagoga modulierten Zuständen und nützliche Verbindungen zur Behandlung von Zuständen durch PYY |
AR077642A1 (es) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo |
JP5934645B2 (ja) | 2009-09-11 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体 |
JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
CN102791704B (zh) | 2010-03-10 | 2015-11-25 | 前体生物药物股份公司 | 谷氨酰胺酰环化酶(qc, ec 2.3.2.5)的杂环抑制剂 |
BR112012025592A2 (pt) | 2010-04-06 | 2019-09-24 | Arena Pharm Inc | moduladores do receptor de gpr119 e o tratamento de distúrbios relacionados com os mesmos |
EP2560953B1 (de) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Hemmer der glutaminylzyklase |
PE20131371A1 (es) | 2010-09-22 | 2013-11-25 | Arena Pharm Inc | Moduladores del receptor gpr119 y el tratamiento de trastornos relacionados con este |
RU2462455C2 (ru) * | 2010-12-01 | 2012-09-27 | Учреждение Российской Академии Наук Институт Проблем Химической Физики Ран (Ипхф Ран) | Способ получения гидроксипроизводных стирилхинолинов |
JP6050264B2 (ja) | 2011-03-16 | 2016-12-21 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
WO2012135570A1 (en) | 2011-04-01 | 2012-10-04 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145361A1 (en) | 2011-04-19 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145604A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145603A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2013055910A1 (en) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2014074668A1 (en) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr119 and the treatment of disorders related thereto |
WO2016144862A1 (en) | 2015-03-09 | 2016-09-15 | Intekrin Therapeutics, Inc. | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
EP3606527A1 (de) | 2017-04-03 | 2020-02-12 | Coherus Biosciences, Inc. | Ppar-gamma-agonist zur behandlung der progressiven supranuklearen blickparese |
DK3461819T3 (da) | 2017-09-29 | 2020-08-10 | Probiodrug Ag | Inhibitorer af glutaminylcyklase |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE122010000020I1 (de) | 1996-04-25 | 2010-07-08 | Prosidion Ltd | Verfahren zur Senkung des Blutglukosespiegels in Säugern |
TW492957B (en) | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
US6011155A (en) | 1996-11-07 | 2000-01-04 | Novartis Ag | N-(substituted glycyl)-2-cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
WO1999038501A2 (en) | 1998-02-02 | 1999-08-05 | Trustees Of Tufts College | Method of regulating glucose metabolism, and reagents related thereto |
DE19834591A1 (de) | 1998-07-31 | 2000-02-03 | Probiodrug Ges Fuer Arzneim | Verfahren zur Steigerung des Blutglukosespiegels in Säugern |
US6469021B1 (en) * | 1998-12-10 | 2002-10-22 | Agouron Pharmaceuticals, Inc. | Non-peptide antagonists of GLP-1 receptor and methods of use |
CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
US6110949A (en) | 1999-06-24 | 2000-08-29 | Novartis Ag | N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
EP1088818B1 (de) * | 1999-10-01 | 2004-11-03 | F. Hoffmann-La Roche Ag | Chinolin-4-yl-derivate |
US6440995B1 (en) * | 1999-10-01 | 2002-08-27 | Hoffman-La Roche Inc. | Quinolin-4-yl derivatives |
GB9928330D0 (en) | 1999-11-30 | 2000-01-26 | Ferring Bv | Novel antidiabetic agents |
AU2001228309A1 (en) | 2000-01-24 | 2001-08-07 | Novo-Nordisk A/S | N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv |
GB0010188D0 (en) * | 2000-04-26 | 2000-06-14 | Ferring Bv | Inhibitors of dipeptidyl peptidase IV |
TW583185B (en) | 2000-06-13 | 2004-04-11 | Novartis Ag | N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same |
-
2003
- 2003-02-05 WO PCT/EP2003/001112 patent/WO2003068748A1/en active IP Right Grant
- 2003-02-05 JP JP2003567879A patent/JP4216197B2/ja not_active Expired - Fee Related
- 2003-02-05 CN CNB038037750A patent/CN1308311C/zh not_active Expired - Fee Related
- 2003-02-05 ES ES03704539T patent/ES2252656T3/es not_active Expired - Lifetime
- 2003-02-05 MX MXPA04007743A patent/MXPA04007743A/es active IP Right Grant
- 2003-02-05 CA CA002474460A patent/CA2474460C/en not_active Expired - Fee Related
- 2003-02-05 DE DE60302336T patent/DE60302336T2/de not_active Expired - Lifetime
- 2003-02-05 AT AT03704539T patent/ATE309988T1/de active
- 2003-02-05 AU AU2003206834A patent/AU2003206834B2/en not_active Ceased
- 2003-02-05 PL PL03372488A patent/PL372488A1/xx not_active Application Discontinuation
- 2003-02-05 EP EP03704539A patent/EP1476429B1/de not_active Expired - Lifetime
- 2003-02-05 RU RU2004127578/04A patent/RU2285693C2/ru not_active IP Right Cessation
- 2003-02-05 BR BR0307576-1A patent/BR0307576A/pt not_active IP Right Cessation
- 2003-02-05 KR KR1020047012463A patent/KR100618752B1/ko not_active IP Right Cessation
- 2003-02-10 PA PA20038566201A patent/PA8566201A1/es unknown
- 2003-02-11 AR ARP030100424A patent/AR038419A1/es not_active Application Discontinuation
- 2003-02-11 US US10/364,490 patent/US6800650B2/en not_active Expired - Fee Related
- 2003-02-12 TW TW092102864A patent/TW200303303A/zh unknown
- 2003-02-12 PE PE2003000152A patent/PE20030922A1/es not_active Application Discontinuation
- 2003-02-12 GT GT200300038A patent/GT200300038A/es unknown
- 2003-02-12 UY UY27666A patent/UY27666A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003068748A9 (en) | 2004-10-07 |
BR0307576A (pt) | 2005-01-11 |
PL372488A1 (en) | 2005-07-25 |
AU2003206834A1 (en) | 2003-09-04 |
US20030195188A1 (en) | 2003-10-16 |
DE60302336D1 (de) | 2005-12-22 |
UY27666A1 (es) | 2003-08-29 |
PE20030922A1 (es) | 2003-11-08 |
CN1308311C (zh) | 2007-04-04 |
DE60302336T2 (de) | 2006-08-03 |
KR100618752B1 (ko) | 2006-08-31 |
EP1476429A1 (de) | 2004-11-17 |
AR038419A1 (es) | 2005-01-12 |
GT200300038A (es) | 2003-09-23 |
JP4216197B2 (ja) | 2009-01-28 |
RU2004127578A (ru) | 2005-08-10 |
PA8566201A1 (es) | 2003-12-19 |
TW200303303A (en) | 2003-09-01 |
US6800650B2 (en) | 2004-10-05 |
CN1630639A (zh) | 2005-06-22 |
AU2003206834B2 (en) | 2006-10-19 |
ES2252656T3 (es) | 2006-05-16 |
MXPA04007743A (es) | 2004-10-15 |
RU2285693C2 (ru) | 2006-10-20 |
JP2005526034A (ja) | 2005-09-02 |
EP1476429B1 (de) | 2005-11-16 |
WO2003068748A1 (en) | 2003-08-21 |
CA2474460A1 (en) | 2003-08-21 |
KR20040081788A (ko) | 2004-09-22 |
CA2474460C (en) | 2009-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE309988T1 (de) | Neue pyridin- und quinolin-derivate | |
ATE472536T1 (de) | Pyridin- und pyrimidin-derivate | |
DE60209734D1 (de) | Tetrahydrochinolin-derivate | |
IS8439A (is) | Nýjar kínólín afleiður | |
ATE422495T1 (de) | Antibakterielle naphthydrin- und quinolinderivate | |
DE60328671D1 (de) | Neue aminobenzamidderivate | |
IS7659A (is) | COX-2 hamlandi pýridín afleiður | |
NO20031097D0 (no) | Kinolinderivater | |
DK1427709T3 (da) | 3-substituerede 4-pyrimidonderivater | |
DK1497266T3 (da) | Quinolinderivater og deres anvendelse som 5HT6-ligander | |
DE60336811D1 (de) | Neue benzimidazolderivate | |
DK1527067T3 (da) | 4-Trifluormethylpyrazolylsubstituerede pyridiner og pyrimidiner | |
DE60319951D1 (de) | Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate | |
IL174497A0 (en) | Pyridine derivatives and use thereof as urotensin ii antagonists | |
DE50202178D1 (de) | Neue sulfonat-substituierte pyrazolopyridinderivate | |
ATE423117T1 (de) | Heterocyclische 7-aminoalkylidenylchinolone und - naphthyridone | |
DE10163359B4 (de) | Pyridinderivat und dessen Komplex | |
ATE403646T1 (de) | Aminocyclohexan-derivate | |
DE60117096D1 (de) | Dihydroindol- und tetrahydrochinolinderivate | |
ATE299873T1 (de) | Substituierte c-furan-2-yl-methylamin- und c- thiophen-2-yl-methylamin-derivate | |
DK1480970T3 (da) | Quinolinderivater | |
DK1366039T3 (da) | Piperazinylcarbonylquinoliner og -isoquinoliner | |
DE10195304D2 (de) | Chinolin-Derivative und ihre Verwendung | |
DE60206043D1 (de) | Neue indolderivate | |
IS7870A (is) | Tetrahýdrókínólín afleiður |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1476429 Country of ref document: EP |